Intensity Therapeutics Analyst Ratings
Intensity Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/24/2023 | 101.34% | Benchmark | → $12 | Reiterates | Speculative Buy → Speculative Buy |
| 07/18/2023 | 101.34% | Benchmark | → $12 | Initiates Coverage On | → Speculative Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年08月24日 | 101.34% | 基准 | →$12 | 重申 | 投机性买入→投机性买入 |
| 07/18/2023 | 101.34% | 基准 | →$12 | 开始承保 | →投机性买入 |
What is the target price for Intensity Therapeutics (INTS)?
强度治疗(INTS)的目标价格是多少？
The latest price target for Intensity Therapeutics (NASDAQ: INTS) was reported by Benchmark on August 24, 2023. The analyst firm set a price target for $12.00 expecting INTS to rise to within 12 months (a possible 101.34% upside). 2 analyst firms have reported ratings in the last year.
强度治疗公司(纳斯达克：INTS)的最新目标价于2023年8月24日由Benchmark报告。这家分析公司将目标价定为12美元，预计INT将在12个月内上涨(可能上涨101.34%)。去年有两家分析公司公布了评级。
What is the most recent analyst rating for Intensity Therapeutics (INTS)?
强度治疗(INTS)的最新分析师评级是多少？
The latest analyst rating for Intensity Therapeutics (NASDAQ: INTS) was provided by Benchmark, and Intensity Therapeutics reiterated their speculative buy rating.
强度治疗公司(纳斯达克代码：INTS)的最新分析师评级是由Benchmark提供的，强度治疗公司重申了他们的投机性买入评级。
When is the next analyst rating going to be posted or updated for Intensity Therapeutics (INTS)?
下一次强度治疗(INTS)的分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Intensity Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Intensity Therapeutics was filed on August 24, 2023 so you should expect the next rating to be made available sometime around August 24, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与强度治疗公司的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。强度治疗的上一次评级是在2023年8月24日提交的，所以你应该预计下一次评级将在2024年8月24日左右提供。
Is the Analyst Rating Intensity Therapeutics (INTS) correct?
分析师对强度治疗(INTS)的评级正确吗？
While ratings are subjective and will change, the latest Intensity Therapeutics (INTS) rating was a reiterated with a price target of $0.00 to $12.00. The current price Intensity Therapeutics (INTS) is trading at is $5.96, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的强度治疗(INTS)评级被重申，目标价在0.00美元至12.00美元之间。目前强度治疗公司(INTS)的交易价格为5.96美元，在分析师的预测范围内。